All articles by Manish Kumar
Manish Kumar
Biogennix launches Agilon Surgical Matrix
Osteobiologics Leader Enters Wound Care Space with Cutting Edge Solution
Smart Meter introduces multi-cuff iBloodPressure Classic BP monitor
iBloodPressure Classic is a cellular-connected, multi-cuff BP monitor that offers more precision, inclusivity, and access to comprehensive health insights for patients with chronic illnesses
Crown Laboratories acquires Healeon’s assets and technology
The acquisition of Healeon’s assets and technology is expected to enhance Crown’s position in the PRP sector, particularly with its ProGen PRP Eclipse brand.
Sutter Health deploys world’s first wearable Doppler Ultrasound Patch to enhance safety of ICU patients
The FDA-cleared device gives ICU clinicians a fast, hands-free method of assessing blood-flow at the bedside to help guide cardiopulmonary resuscitation and fluid management in critically ill patients
Lunit deploys Lunit INSIGHT MMG in Qatar’s breast cancer programme
The AI solution will enhance early detection of breast cancer, reducing the occurrence of missed diagnoses and improving survival rates in Qatar’s triennial screening programme
CEPI to grant $41.3m to Valneva for Ixchiq chikungunya vaccine trials
Valneva and CEPI will expand access to Ixchiq in LMICs and support in conducting post-marketing trials and exploring potential label extensions for children, adolescents, and pregnant women
Samsara Vision announces first SING IMT patient in China and accelerating global rollout
The SING IMT is a Galilean intraocular telescope designed to improve visual acuity and quality of life for patients with late-stage AMD
Commure to acquire healthcare AI firm Augmedix for $139m
Augmedix uses ambient AI technology and data to convert natural conversations into medical notes, structured data, and real-time notifications to boost efficiency and clinical decision-making
QingSong Health and Globethics to advance AI ethics in healthcare
The collaboration aims to advance ethical standards in AI technology within healthcare, foster education on philanthropic ethics, and bolster global cooperation on AI ethics
More than 40,000 people could benefit after NICE recommends new ‘take at home’ pill for advanced prostate cancer
Thousands of people could benefit from a new oral hormone therapy for advanced hormone sensitive prostate cancer